Actively Recruiting
Newborns From Patients Treated With ART (Assisted Reproductive Technology)
Led by The First Affiliated Hospital of Zhengzhou University · Updated on 2019-06-20
10000
Participants Needed
1
Research Sites
2139 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Prospective Cohort Study for Newborns from patients treated with ART was set up to investigate the short- and long-term health consequences in Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University, China.
CONDITIONS
Official Title
Newborns From Patients Treated With ART (Assisted Reproductive Technology)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All newborns from patients treated with ART in our center.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Reproductive Medical Center, First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China, 450052
Actively Recruiting
Research Team
L
Lanlan Fang, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here